Arianna Gonelli

Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells.

Stefano A Pileri, Claudio Agostinelli, S. Pileri, 2005, American Journal of Pathology.

The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies.

P. Secchiero, A. Gonelli, G. Zauli, 2008, Current pharmaceutical design.

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

Hansjuerg Alder, Cristian Taccioli, Mario Acunzo, 2009, Cancer cell.

Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3

A. Albini, P. Secchiero, F. Corallini, 2007, Circulation research.